Last year the company failed an attempt to sell its pathology business to raise $100 million. At the same time,it suffered heavy losses. Now they want to issue new subordinated notes. Does it ring the bell?
- Forums
- ASX - By Stock
- Ann: Healthscope Notes II - Interest Rate
HLN
healthscope notes limited
Last year the company failed an attempt to sell its pathology...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online